Caresyntax Corporation, a leader in surgical data integration and intelligence, has announced a strategic collaboration with The Jacobs Institute, Inc. (JI), a non-profit innovation center focused on vascular medical technology. This partnership aims to enhance the utilization of Real-World Evidence (RWE) for product evaluation and to improve patient outcomes.
The Jacobs Institute is joining the Caresyntax Clinical Innovation Network as a key partner. This partnership combines Caresyntax’s data science and real-world evidence methods with The Jacobs Institute’s expertise in vascular surgery. Together, they aim to improve the evaluation of procedures and devices throughout the entire care process using Caresyntax’s vendor-neutral real-world evidence engine.
The Caresyntax Clinical Innovation Network brings together leading healthcare institutions that focus on improving healthcare through data. Members can access the full range of Caresyntax Clinical Quality Improvement (CQI) partnerships. In these projects, Caresyntax gathers and analyzes real-world data for MedTech companies to help them understand what affects patients during surgery. These studies provide a more cost-effective and patient-friendly option compared to traditional clinical trials, which helps MedTech companies use and adopt their medical devices more effectively.
This partnership aligns with the Jacobs Institute’s mission to promote research models focused on innovations in vascular disease. Additionally, it enhances the Institute’s role and capabilities as a leading research institution dedicated to improving surgical care and patient outcomes.
“Partnering with Caresyntax provides a powerful new tool to take our relationships with industry partners to the next level,” said Adnan H. Siddiqui, MD, CEO & CMO of The Jacobs Institute. “This collaboration enables us to support the broader healthcare ecosystem by facilitating the generation of high-quality Real-World Evidence, which is essential for advancing medical technology and improving patient care standards globally. We look forward to seeing the positive impact of this initiative.“
This partnership marks a significant step forward in leveraging clinical quality improvement, data curation algorithms, and data systems science to enhance surgical care and accelerate the development of effective medical technologies.
